Who We Are

Our competition practice is focused on helping clients in cartel investigations, claims against clients arising from alleged abuse of dominance and compliance with existing competition law. Our merger clearance team is notorious for doing almost magic. We eagerly represent clients against the Competition Authority, including litigation against unfavourable decisions.

Practice In Detail
  • Abuse of Dominance
  • Anti-Competitive Behaviour
  • Cartel Investigation
  • Competition Litigation
  • Compliance
  • Dawn Raids
  • Horizontal and Vertical Agreements
  • Information Exchange
  • International Trade
  • Joint Ventures
  • Merger Control
  • Public-Procurement
  • State Aid
  • Tenders
  • AGA
  • AirBaltic
  • BAO
  • Cido Grupa
  • Deep White
  • ENC Latvia
  • Firma Madara 89
  • Fragrances International
  • Iepirkumu grupa
  • If P&C Insurance
  • KW Bruun Baltic
  • Latvijas Mobilais Telefons
  • Latvijas Pārtikas tirgotāju asociācija
  • Latvijas Pasts
  • Moller Baltic Import
  • Narvesen
  • RCI Gulbene
  • RIMI
  • Specprojekts
  • Triangel
  • Zaļā josta


Advising a leading retail chain in the Baltics on the EU competition aspects of a proposed joint purchasing agreement.

AT&T on the merger control aspects of its US$85.4 billion acquisition of Time Warner.

Cisco on the merger control aspects of its US$1.9 billion acquisition of BroadSoft.

Monsanto on the merger control aspects of its US$63 billion acquisition by Bayer.

An Investment fund in the merger control aspects of a potential transaction.

A company regarding the purchase of cartel participant and the potential implications as a result.

A leading pharmaceutical company concerning potential competition issues arising in its pricing practices.

Schlumberger on the merger control aspects of its US$14.8 billion purchase of Cameron.

Marriot on the merger control aspects of its $13.6bn purchase of Starwood Hotels.

St. Jude Medical on the merger control aspects of its US$25 billion acquisition by Abbott.

Key Contacts